PF-Atlas › Mechanisms › Target LAMB3+/KRT17+ aberrant cells — remove pro-fibrotic signal source
Target LAMB3+/KRT17+ aberrant cells — remove pro-fibrotic signal source in IPF
Mechanism of action · idiopathic pulmonary fibrosis
Overview
Target LAMB3+/KRT17+ aberrant cells — remove pro-fibrotic signal source is a therapeutic target in idiopathic pulmonary fibrosis. PF-Atlas tracks 1 drug and 0 clinical trials acting through this mechanism.
Drugs targeting Target LAMB3+/KRT17+ aberrant cells — remove pro-fibrotic signal source
Therapies
Medical disclaimer. This is a research summary, not medical advice.